US$ 24.56
obesity treatment with bariatric surgery vs glp-1 receptor agonists Comparing GLP‑1 Drugs Other Weight Loss Methods: Diet & Exercise, Surgery, and Lifestyle Programs -Pros & Cons Bariatric Surgery or GLP-1's: Which
Description
Curran-Everett, D

How do you inject / administer Zepbound

AT A GLANCE Originally FDA-approved for type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) also lead to sustained weight loss and have revolutionized diabetes and obesity management

doi: 10.1016/S2213-2600(15)00043-0, 4

The result is a data asset that allows your team to analyze the full obesity patient journey in one place , without the pain of stitching together fragmented data sources
